Toll-like receptors signaling in glomerular diseases

References

• Chen K, Huang J, Gong W, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007;7:1271--85
   PubMed Web of Science ®Google Scholar
• Smith KD. Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens 2009;18:189–96
   PubMed Web of Science ®Google Scholar
• Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003;85:85–95
   PubMed Web of Science ®Google Scholar
• Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure 2011;19:447–59
   PubMed Web of Science ®Google Scholar
• Zhou TB. Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis. J Recept Signal Transduct Res 2012;32:285–9
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH. The potential mechanism for the different expressions of gelatinases induced by all-trans retinoic acid in different cells. J Recept Signal Transduct Res 2012;32:129–33
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335–76
   PubMed Web of Science ®Google Scholar
• Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004;430:257–63
   PubMed Web of Science ®Google Scholar
• Sato K, Ishikawa T, Okumura A, et al. Expression of Toll-like receptors in chronic hepatitis C virus infection. J Gastroenterol Hepatol 2007;22:1627–32
   PubMed Web of Science ®Google Scholar
• Ding JL, Zhou ZG, Zhou XY, et al. Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: the effect on Toll-like receptor signaling pathways. Pancreas 2013;42:114–22
   Google Scholar
• Zheng L, Riehl TE, Stenson WF. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid. Gastroenterology 2009;137:2041–51
   PubMed Web of Science ®Google Scholar
• Song WC. Crosstalk between complement and toll-like receptors. Toxicol Pathol 2012;40:174–82
   PubMed Web of Science ®Google Scholar
• Turco F, Sarnelli G, Cirillo C, et al. Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut 2013. [Epub ahead of print]
   Google Scholar
• Bourguignon LY, Wong G, Earle CA, et al. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken) 2011;68:671–93
   Google Scholar
• Liu B, Fu Y, Feng S, et al. Involvement of RP105 and Toll-like receptors in the activation of mouse peritoneal macrophages by Staphylococcus aureus. Scand J Immunol 2013. [Epub ahead of print]. doi: 10. 1111/sji.12050
   Google Scholar
• Curtale G, Mirolo M, Renzi TA, et al. Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA 2013;110:11499--504
   PubMed Web of Science ®Google Scholar
• Wang H, Brown J, Gao S, et al. The role of JAK-3 in regulating TLR-mediate inflammatory cytokine production in innate immune cells. J Immunol 2013;191:1164--74
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang P, Bao Y, et al. Zinc finger protein ZBTB20 promotes toll-like receptor-triggered innate immune responses by repressing IκBα gene transcription. Proc Natl Acad Sci U S A 2013;110:11097–102
   PubMed Web of Science ®Google Scholar
• Katoh S, Honda S, Watanabe T, et al. Atrial endothelial impairment through Toll-like receptor 4 signaling causes atrial thrombogenesis. Heart Vessels 2013. [Epub ahead of print]
   Google Scholar
• van Vliet SJ, Bay S, Vuist IM, et al. MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion. J Leukoc Biol 2013;94:315--23
   Google Scholar
• Tayel SS, Helmy AA, Ahmed R, et al. Progesterone suppresses interferon signaling by repressing TLR-7 and MxA expression in peripheral blood mononuclear cells of patients infected with hepatitis C virus. Arch Virol 2013;158:1755--64
   Google Scholar
• Li B, Baylink DJ, Deb C, et al. 1,25-dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS One 2013;8:e58808
   PubMed Web of Science ®Google Scholar
• Huang S, Miao R, Zhou Z, et al. MCPIP1 negatively regulates toll-like receptor 4 signaling and protects mice from LPS-induced septic shock. Cell Signal 2013;25:1228–34
   Google Scholar
• Cai M, Li M, Wang K, et al. The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. PLoS One 2013;8:e54586
   Google Scholar
• Sharma N, Akhade AS, Qadri A, et al. Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. J Leukoc Biol 2013;93:521–8
   Google Scholar
• Piao W, Vogel SN, Toshchakov VY. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo. J Immunol 2013;190:2263–2272
   Google Scholar
• Wen R, Li F, Sun Z, et al. Shrimp MyD88 responsive to bacteria and white spot syndrome virus. Fish Shellfish Immunol 2013;34:574–81
   Google Scholar
• Jaedicke KM, Roythorne A, Padget K, et al. Leptin up-regulates TLR2 in human monocytes. J Leukoc Biol 2013;93:561–71
   PubMed Web of Science ®Google Scholar
• Yee NK, Hamerman JA. β(2) integrins inhibit TLR responses by regulating NF-κB pathway and p38 MAPK activation. Eur J Immunol 2013;43:779–92
   Google Scholar
• Pimentel-Nunes P, Gonçalves N, Boal-Carvalho I, et al. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter 2013;18:22–32
   PubMed Web of Science ®Google Scholar
• Wu D, Lee YC, Liu HC, et al. Identification of TLR downstream pathways in stroke patients. Clin Biochem 2013;46:1058--64
   Google Scholar
• Meyer F, Ehlers E, Steadman A, et al. TLR-TRIF pathway enhances the expression of KSHV replication and transcription activator. J Biol Chem 2013;288:20435--42
   Google Scholar
• Zhang L, Che C, Lin J, et al. TLR-mediated induction of proinflammatory cytokine IL-32 in corneal epithelium. Curr Eye Res 2013;38:630–8
   PubMed Web of Science ®Google Scholar
• Zhang S, Nie S, Huang D, et al. Polysaccharide from Ganoderma atrum evokes antitumor activity via Toll-like receptor 4-mediated NF-κB and mitogen-activated protein kinase signaling pathways. J Agric Food Chem 2013;61:3676–82
   PubMed Web of Science ®Google Scholar
• Lim H, Kim D, Lee SJ. Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cordmicroglia. J Biol Chem 2013;288:7572–9
   Google Scholar
• Lai L, Song Y, Liu Y, et al. MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase. J Biol Chem 2013;288:7956–67
   PubMed Web of Science ®Google Scholar
• Melkamu T, Kita H, O'Grady SM. TLR3 activation evokes IL-6 secretion, autocrine regulation of Stat3 signaling and TLR2 expression in human bronchial epithelial cells. J Cell Commun Signal 2013;7:109–18
   PubMed Web of Science ®Google Scholar
• Nyström S, Antoine DJ, Lundbäck P, et al. TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J 2013;32:86–99
   PubMed Web of Science ®Google Scholar
• Waltz P, Carchman EH, Young AC, et al. Lipopolysaccaride induces autophagic signaling in macrophages via a TLR4, heme oxygenase-1 dependent pathway. Autophagy 2011;7:315–20
   PubMed Web of Science ®Google Scholar
• Lee GL, Chang YW, Wu JY, et al. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production. Arterioscler Thromb Vasc Biol 2012;32:2751–60
   PubMed Web of Science ®Google Scholar
• Li H, Xu H, Liu S. Toll-like receptors 4 induces expression of matrix metalloproteinase-9 in human aortic smooth muscle cells. Mol Biol Rep 2011;38:1419–23
   Google Scholar
• Takata S, Sawa Y, Uchiyama T, et al. Expression of toll-like receptor 4 in glomerular endothelial cells under diabetic conditions. Acta Histochem Cytochem 2013;46:35–42
   Google Scholar
• Urbonaviciute V, Starke C, Pirschel W, et al. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. Arthritis Rheum 2013;65:1612–23
   Google Scholar
• Lin M, Yiu WH, Li RX, et al. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int 2013;83:887–900
   PubMed Web of Science ®Google Scholar
• Kaur H, Chien A, Jialal I. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 2012;303:F1145–50
   Google Scholar
• Shimada M, Ishimoto T, Lee PY, et al. Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway. Nephrol Dial Transplant 2012;27:81–9
   PubMed Web of Science ®Google Scholar
• Devaraj S, Tobias P, Kasinath BS, et al. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol 2011;31:1796–804
   PubMed Web of Science ®Google Scholar
• Summers SA, Steinmetz OM, Gan PY, et al. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. Arthritis Rheum 2011;63:1124–35
   PubMedGoogle Scholar
• Koc M, Toprak A, Arikan H, et al. Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation. Nephrol Dial Transplant 2011;26:955–63
   PubMed Web of Science ®Google Scholar
• Papadimitraki ED, Tzardi M, Bertsias G, et al. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response. Lupus 2009;18:831–5
   PubMed Web of Science ®Google Scholar
• Anders HJ, Vielhauer V, Eis V, et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 2004;18:534–6
   PubMed Web of Science ®Google Scholar
• Pawar RD, Patole PS, Zecher D, et al. Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol 2006;17:141–9
   Google Scholar
• Brown HJ, Sacks SH, Robson MG, et al. Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol 2006;17:1931–9
   Google Scholar